Statistics for Use of half-generation PAMAM dendrimers (G0. 5–G3. 5) with carboxylate end-groups to improve the DACHPtCl2 and 5-FU efficacy as anticancer drugs
Total visits
| views | |
|---|---|
| Use of half-generation PAMAM dendrimers (G0. 5–G3. 5) with carboxylate end-groups to improve the DACHPtCl2 and 5-FU efficacy as anticancer drugs | 30 |
Total visits per month
| views | |
|---|---|
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
| September 2025 | 0 |
| October 2025 | 0 |
File Visits
| views | |
|---|---|
| Use of half-generation PAMAM dendrimers (G0. 5–G3. 5) with carboxylate end-groups to improve the DACHPtCl2 and 5-FU efficacy as anticancer drugs.pdf | 44 |
Top country views
| views | |
|---|---|
| China | 8 |
| United States | 6 |
| Australia | 5 |
| Portugal | 3 |
| Ireland | 2 |
| Brazil | 1 |
| Canada | 1 |
| Germany | 1 |
| Israel | 1 |
| Mongolia | 1 |
| Sweden | 1 |